Please login to the form below

Not currently logged in
Email:
Password:

UK women 'unaware' of HPV cancer link

According to research published in the British Journal of Cancer, a large majority of UK women did not know that most cervical cancer is caused by a sexually transmitted infection.

According to research published in the British Journal of Cancer, a large majority of UK women did not know that most cervical cancer is caused by a sexually transmitted infection.

In a survey of 1,600 women, only 2.5 per cent cited human papillomavirus (HPV) as a risk factor for cervical cancer. Researchers said the results were "striking" considering recent publicity over the development of a HPV vaccine.

Merck & Co's Gardasil and GlaxoSmithKline's (GSK) Cervarix HPV vaccines have both demonstrated efficacy against the strains most commonly linked with cervical cancer. Gardasil reached market first.

In June 2007, advisors to the UK government recommended vaccinating girls aged between 12 and 13 years and also suggested that HPV testing should be combined with cervical screening.

The survey which was performed at the beginning of 2007 showed a three-fold increase in the number of women who were able to list HPV as a cause of the infection - but the figure is still "extraordinarily low", concluded the researchers.

13th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics